Figure 8
(A) Correlation between XBP1 and 13 inhibitory immune checkpoints. (B) Correlation between XBP1 and four immune checkpoints (PD-L1, CTLA-4, PD-1 and LAG-3) based on GETx dataset. (C) Correlation between XBP1 and four immune checkpoints (PD-L1, CTLA-4, PD-1 and LAG-3) based on TCGA dataset. The dots represent cancer types or tissue types, red dots represent BC or breast tissue. The Y-axis represents the Pearson correlation, while the X-axis represents -log10P. (D) Differences in the enrichment scores of immunotherapy-predicted pathways between high and low XBP1 groups.
Correlation between XBP1 and inhibitory immune checkpoints

(A) Correlation between XBP1 and 13 inhibitory immune checkpoints. (B) Correlation between XBP1 and four immune checkpoints (PD-L1, CTLA-4, PD-1 and LAG-3) based on GETx dataset. (C) Correlation between XBP1 and four immune checkpoints (PD-L1, CTLA-4, PD-1 and LAG-3) based on TCGA dataset. The dots represent cancer types or tissue types, red dots represent BC or breast tissue. The Y-axis represents the Pearson correlation, while the X-axis represents -log10P. (D) Differences in the enrichment scores of immunotherapy-predicted pathways between high and low XBP1 groups.

Close Modal

or Create an Account

Close Modal
Close Modal